Male AGA (Hamilton-Norwood IIv–V): what to do when Dutasteride failed to stop hair loss and induce regrowth
This protocol is for male patients aged 18 or older with mild to moderate androgenetic alopecia (Hamilton-Norwood stages IIv through V) whose prior treatment with Dutasteride did not achieve the required clinical goals, making escalation to the next therapeutic line necessary.
Clinical scenario
Male sex · Age 18 years or older · Mild to moderate androgenetic alopecia, classified Hamilton-Norwood IIv–V.
Previous treatment — documented failure
Prior therapy: Oral Dutasteride
Goals not achieved: cessation of ongoing hair loss and induction of measurable hair regrowth (increased hair count). Failure to reach these targets on Dutasteride is the escalation criterion that triggers this next-line protocol.
Next-line approach (overview)
The next step involves a
surgical intervention — a form of follicular unit transplantation — considered when the patient has sufficient donor hair. This surgical approach is combined with an oral medical therapy to optimise the clinical result.
The full selection criteria, candidacy assessment, sequencing, and clinical decision algorithm are available in the complete protocol.
Treatment goals
Cosmetic recovery of hairless areas
Final result assessed at 9–12 months
References
DOI: 10.1111/jdv.14624
- Surgery, especially follicular unit transplantation (FUT) can be considered in male patients with sufficient donor hair.
- We suggest follicular unit transplantation (FUT) to be combined with finasteride 1 mg daily to achieve a better clinical outcome.
- The final result can be evaluated at 9–12 months.
View source ↗